Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Reinstituting Natural Killer Cell Cytotoxicity and Cytoskeletal Dynamics in Wiskott-Aldrich Syndrome With IL-2 Therapy

NCT00774358 is registered in ClinicalTrials.gov with Soma Jyonouchi as lead sponsor.

NCT NCT00774358
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00774358 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Reinstituting Natural Killer Cell Cytotoxicity and Cytoskeletal Dynamics in Wiskott-Aldrich Syndrome With IL-2 Therapy
Lead sponsor
Soma Jyonouchi
Phase
Phase 1
Overall status
Completed
Start date
October 31, 2008
Completion date
September 30, 2016
Enrollment
9 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

wiskott-aldrich syndrome (was), x-linked thrombocytopenia